- Tytuł:
- Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)
- Autorzy:
- Źródło:
- In Clinical and Translational Radiation Oncology March 2022 33:115-119
Czasopismo naukowe